M&A Deal Summary |
|
---|---|
Date | 2016-01-07 |
Target | WIL Research |
Sector | Life Science |
Buyer(s) | Charles River Laboratories International |
Deal Type | Add-on Acquisition |
Deal Value | 585M USD |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1947 |
Sector | Life Science |
Employees | 20,400 |
Revenue | 4.1B USD (2023) |
Charles River Laboratories International is a provider of essential products and contract services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. Charles River Laboratories International was incorporated in 1947 and is based in Wilmington, Massachusetts.
DEAL STATS | # |
---|---|
Overall | 17 of 31 |
Sector (Life Science) | 14 of 28 |
Type (Add-on Acquisition) | 12 of 26 |
State (Ohio) | 2 of 2 |
Country (United States) | 9 of 20 |
Year (2016) | 1 of 3 |
Size (of disclosed) | 4 of 17 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2015-11-19 |
Oncotest
Freiburg, Germany Oncotest GmbH is a contract research organization (CRO) that provides discovery services for oncology. |
Buy | €34M |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2016-06-27 |
Blue Stream Laboratories
Woburn, Massachusetts, United States Blue Stream Laboratories, Inc. is an analytical contract research organization (CRO) supporting the development of complex biologics and biosimilars. Located in Woburn, Massachusetts, the company is recognized for its expertise in structural and functional protein characterization programs, and the development and validation of assays for current good manufacturing practice (cGMP) lot release and stability programs. Protein characterization is the key element for development and registration of biologic and biosimilar entities. |
Buy | - |